Metropolitan Life Insurance Company (MetLife)’s Silicon Laboratories SLAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,669
| Closed | -$240K | – | 1786 |
|
|
2024
Q1 | $240K | Sell |
1,669
-159
| -9% | -$21.1K | 0.01% | 650 |
|
|
2023
Q4 | $242K | Hold |
1,828
| – | – | 0.01% | 658 |
|
|
2023
Q3 | $212K | Buy |
1,828
+92
| +5% | +$12.7K | 0.01% | 651 |
|
|
2023
Q2 | $274K | Buy |
1,736
+29
| +2% | +$4.38K | 0.01% | 567 |
|
|
2023
Q1 | $299K | Sell |
1,707
-331
| -16% | -$55.6K | 0.02% | 540 |
|
|
2022
Q4 | $276K | Sell |
2,038
-5
| -0.2% | -$657 | 0.01% | 588 |
|
|
2022
Q3 | $252K | Sell |
2,043
-145
| -7% | -$19.4K | 0.01% | 598 |
|
|
2022
Q2 | $307K | Sell |
2,188
-161
| -7% | -$22.5K | 0.01% | 564 |
|
|
2022
Q1 | $353K | Sell |
2,349
-14,154
| -86% | -$2.26M | 0.01% | 602 |
|
|
2021
Q4 | $3.41M | Sell |
16,503
-1,725
| -9% | -$318K | 0.05% | 329 |
|
|
2021
Q3 | $2.55M | Sell |
18,228
-1,548
| -8% | -$232K | 0.04% | 399 |
|
|
2021
Q2 | $3.03M | Buy |
19,776
+887
| +5% | +$124K | 0.04% | 346 |
|
|
2021
Q1 | $2.66M | Sell |
18,889
-33
| -0.2% | -$4.73K | 0.04% | 392 |
|
|
2020
Q4 | $2.41M | Sell |
18,922
-773
| -4% | -$87.1K | 0.04% | 407 |
|
|
2020
Q3 | $1.93M | Sell |
19,695
-998
| -5% | -$100K | 0.03% | 424 |
|
|
2020
Q2 | $2.07M | Sell |
20,693
-2,459
| -11% | -$230K | 0.04% | 390 |
|
|
2020
Q1 | $1.98M | Sell |
23,152
-916
| -4% | -$90.9K | 0.04% | 385 |
|
|
2019
Q4 | $2.79M | Sell |
24,068
-336
| -1% | -$36.8K | 0.04% | 372 |
|
|
2019
Q3 | $2.72M | Sell |
24,404
-687
| -3% | -$74.4K | 0.05% | 353 |
|
|
2019
Q2 | $2.59M | Buy |
25,091
+69
| +0.3% | +$6.66K | 0.04% | 392 |
|
|
2019
Q1 | $2.02M | Sell |
25,022
-248
| -1% | -$20.6K | 0.04% | 489 |
|
|
2018
Q4 | $1.99M | Buy |
25,270
+161
| +0.6% | +$13.4K | 0.04% | 422 |
|
|
2018
Q3 | $2.31M | Buy |
25,109
+9
| +0% | +$880 | 0.04% | 436 |
|
|
2018
Q2 | $2.5M | Buy |
25,100
+635
| +3% | +$63.5K | 0.04% | 402 |
|
|
2018
Q1 | $2.2M | Buy |
24,465
+502
| +2% | +$47.3K | 0.03% | 478 |
|
|
2017
Q4 | $2.12M | Sell |
23,963
-43,212
| -64% | -$3.88M | 0.03% | 511 |
|
|
2017
Q3 | $5.37M | Sell |
67,175
-144
| -0.2% | -$10.7K | 0.03% | 546 |
|
|
2017
Q2 | $4.6M | Buy |
67,319
+863
| +1% | +$62.4K | 0.03% | 628 |
|
|
2017
Q1 | $4.89M | Buy |
66,456
+30
| +0% | +$2.1K | 0.03% | 607 |
|
|
2016
Q4 | $4.32M | Sell |
66,426
-503
| -0.8% | -$31.7K | 0.03% | 661 |
|
|
2016
Q3 | $3.94M | Buy |
66,929
+1,933
| +3% | +$104K | 0.03% | 679 |
|
|
2016
Q2 | $3.17M | Sell |
64,996
-317
| -0.5% | -$15K | 0.02% | 752 |
|
|
2016
Q1 | $2.94M | Buy |
65,313
+2,930
| +5% | +$126K | 0.02% | 759 |
|
|
2015
Q4 | $3.03M | Sell |
62,383
-1,225
| -2% | -$60.6K | 0.02% | 729 |
|
|
2015
Q3 | $2.64M | Buy |
63,608
+216
| +0.3% | +$9.86K | 0.02% | 794 |
|
|
2015
Q2 | $3.42M | Sell |
63,392
-3,471
| -5% | -$186K | 0.02% | 739 |
|
|
2015
Q1 | $3.4M | Buy |
66,863
+1,011
| +2% | +$49.1K | 0.03% | 692 |
|
|
2014
Q4 | $3.14M | Sell |
65,852
-495
| -0.7% | -$21.8K | 0.02% | 760 |
|
|
2014
Q3 | $2.7M | Buy |
66,347
+555
| +0.8% | +$24.4K | 0.02% | 815 |
|
|
2014
Q2 | $3.24M | Buy |
65,792
+31,333
| +91% | +$1.49M | 0.02% | 764 |
|
|
2014
Q1 | $1.8M | Buy |
34,459
+410
| +1% | +$19.8K | 0.01% | 1035 |
|
|
2013
Q4 | $1.48M | Buy |
34,049
+427
| +1% | +$17.5K | 0.01% | 1108 |
|
|
2013
Q3 | $1.44M | Buy |
33,622
+556
| +2% | +$23K | 0.01% | 1100 |
|
|
2013
Q2 | $1.37M | Buy |
+33,066
| New | +$1.37M | 0.01% | 1082 |
|
Other funds holding SLAB
GKIM
Metropolitan Life Insurance Company (MetLife)'s SLAB Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Silicon Laboratories (SLAB) in Q2 2024, closing a stake of 1,669 shares — an estimated $240K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SLAB in Q2 2013 and held it in 44 quarters. The position peaked at $5.37M in Q3 2017. 295 funds tracked by Wall St. Rank hold SLAB as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Silicon Laboratories position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 1,669 Silicon Laboratories shares in Q2 2024, an estimated $240K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Silicon Laboratories in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Silicon Laboratories position peaked at $5.37M in Q3 2017.
- 295 funds tracked by Wall St. Rank held Silicon Laboratories as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.